Plasma-driven biocatalysis with the capillary plasma jet using
rAaeUPO immobilized on ReliZyme EP403 M beads. Conversion of the substrate ETBE utilized H2O2 from direct plasma treatment of the rAaeUPO immobilized on ReliZyme EP403 M. Reaction solution contained 5 ml potassium phosphate buffer (100 mM, pH 7) with 50 mM ETBE. Plasma treatment was performed using the capillary plasma jet as described above, with a water concentration of 6400 ppm in the feed gas at 6 W plasma power. Every 10 min, aliquots were withdrawn for product analysis by GC. Means and standard deviations reflect three experiments.
Plasma-driven biocatalysis with the capillary plasma jet using rAaeUPO immobilized on ReliZyme HFA403 M beads. Conversion of the substrate ETBE utilized H2O2 from direct plasma treatment of the rAaeUPO immobilized on ReliZyme HFA403 M. Reaction solution contained 5 ml potassium phosphate buffer (100 mM, pH 7) with 50 mM ETBE. Plasma treatment was performed using the capillary plasma jet as described above, with a water concentration of 6400 ppm in the feed gas at 6 W plasma power. Every 10 min, aliquots were withdrawn for product analysis by GC. Means and standard deviations represent three experiments.
Plasma-driven biocatalysis with the capillary plasma jet using rAaeUPO immobilized on ReliZyme BU403 M beads. Conversion of the substrate ETBE utilized H2O2 from direct plasma treatment of the rAaeUPO immobilized on ReliZyme BU403 M. Reaction solution contained 5 ml potassium phosphate buffer (100 mM, pH 7) with 50 mM ETBE. Plasma treatment was performed using the capillary plasma jet as described above, with a water concentration of 6400 ppm in the feed gas at 6 W plasma power. Every 10 min, aliquots were withdrawn for product analysis by GC. Means and standard deviations reflect three experiments.